FANTTEST
LIVE

Serial Number

79357956

Owner

Hangzhou Fanttest Biotech Co., Ltd.

Attorney

Andrew W. Chu

Filing Date

Nov 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FANTTEST Trademark

Serial Number: 79357956 • Registration: 7369623

FANTTEST is a trademark filed by Hangzhou Fanttest Biotech Co., Ltd. on November 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Hangzhou Fanttest Biotech Co., Ltd.

Room 201, Building 1,

Entity Type: 16

Trademark Details

Filing Date

November 17, 2022

Registration Date

April 30, 2024

Published for Opposition

February 13, 2024

Goods & Services

Diagnostic reagents for medical purposes; diagnostic preparations for medical purposes; biological preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; reagent paper for medical purposes; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; reagents for use in medical genetic testing for medical gene detection; medicines for human purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicine cases, portable, filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; disinfectants for hygiene purposes; disinfectant wipes; haemostatic pencils; cotton swabs for medical purposes; tincture of iodine; medicinal alcohol

Testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical apparatus and instruments for diagnostic use, namely, apparatus and instruments for medical diagnostic testing in the fields of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; protective clothing for medical purposes, namely, clothing especially for operating rooms, surgical scrub tops, pants, and hats, protective face masks for medical use; sanitary masks; respirators for filtering air for medical purposes; thermometers for medical purposes; gloves for medical purposes; syringes for medical purposes; blood pressure monitors; incontinence bed pads, namely, mattress for incontinence of urine and feces; belts for medical purposes

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 4, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 4, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 4, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 4, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 24, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 10, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 10, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 10, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 10, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 6, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2022 REPR